GB Science Inc (OTCMKTS:GBLX) Has Created An All-Inflammation Treating Cannabinoid-Containing Drug

GBLX Daily Chart

The above price hike came only days after the company made an announcement on one of their novel products receiving a patent. After this announcement, the share price soared from lows of about $.53 to highs of $.73, about 38% increment in their price. This price, however, fell towards the closing time and closed yesterday at $.65 which was still an increment of about 23% from its previous low.

Over the course of this piece, we will more at